Literature DB >> 20477826

Genitourinary involvement in epidermolysis bullosa: clinical presentations and therapeutic challenges.

Abdol-Mohammad Kajbafzadeh1, Azadeh Elmi, Parisa Mazaheri, Saman Shafaat Talab, Delaram Jan.   

Abstract

OBJECTIVES: To present our experience of children with epidermolysis bullosa (EB; a rare bullous disorder of the skin) with genitourinary involvement. PATIENTS AND METHODS: The medical records of eight children diagnosed with EB (six junctional and two dystrophic type) with genitourinary involvement were reviewed retrospectively. The data collected included age, clinical presentation, ultrasonographic findings, voiding cystourethrography, urodynamic and uroflowmetry studies, and the treatment challenges. The outcomes of the interventions were evaluated every 6 months.
RESULTS: The mean age was 2.3 years (range 1 day to 7 years). The most common clinical presentations were urinary retention and voiding difficulty. Meatomy was performed in two of three boys followed by diminution of urological complaints. In children with vesico-ureteric reflux, subureteric injections of bulking agent and ureteric stenting were satisfactory. Detrusor instability and bladder compliance improved after α-blocker therapy. The mean (range) follow-up was 62.6 (11-120) months except for two who died in early infancy.
CONCLUSIONS: Considering the potential urological involvement in every child with EB it is essential to provide patients with early appropriate treatment. Management of urological problems should preferably be in a way to entail minimal interventions and if required be performed using small sized instruments. Medical therapy seems promising for voiding dysfunction in this subset of patients.
© 2010 THE AUTHORS. JOURNAL COMPILATION © 2010 BJU INTERNATIONAL.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20477826     DOI: 10.1111/j.1464-410X.2010.09399.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  7 in total

Review 1.  [Mucosal manifestations of epidermolysis bullosa : Clinical presentation and management].

Authors:  C Prodinger; A Diem; J W Bauer; M Laimer
Journal:  Hautarzt       Date:  2016-10       Impact factor: 0.751

Review 2.  [Hereditary epidermolysis bullosa in school children and adolescents. Clinical picture and interdisciplinary management].

Authors:  H Ott; C Eich; K Schriek; B Ludwikowski
Journal:  Hautarzt       Date:  2016-04       Impact factor: 0.751

3.  Evidence for pelvic organ prolapse predisposition genes on chromosomes 10 and 17.

Authors:  Kristina Allen-Brady; Lisa A Cannon-Albright; James M Farnham; Peggy A Norton
Journal:  Am J Obstet Gynecol       Date:  2014-12-31       Impact factor: 8.661

Review 4.  Emergency management in epidermolysis bullosa: consensus clinical recommendations from the European reference network for rare skin diseases.

Authors:  Jemima E Mellerio; Maya El Hachem; Nathalia Bellon; Giovanna Zambruno; Hana Buckova; Rudolf Autrata; Carmen Salavastru; Tamara Caldaro; Celine Greco; Cristina Has; Christine Bodemer
Journal:  Orphanet J Rare Dis       Date:  2020-06-06       Impact factor: 4.123

5.  Identification of a novel homozygous LAMB3 mutation in a Chinese male with junctional epidermolysis bullosa and severe urethra stenosis: A case report.

Authors:  Wei Wang; Qiang Guo; Jinshan Chen; Xi Zhang; Chengyong Li; Shuangping Li; Jialin Liang; Chuan Hao; Jingqi Wang
Journal:  Front Genet       Date:  2022-09-30       Impact factor: 4.772

6.  Vesicostomy as a Treatment Option for Epidermolisis Bullosa Case With Urethral and Meatal Involvement.

Authors:  Mahmoudreza Moradi; Haress Rezaee; Kaveh Kaseb; Ali Ebrahimi
Journal:  Urol Case Rep       Date:  2016-05-09

7.  Exogenous supply of Hsp47 triggers fibrillar collagen deposition in skin cell cultures in vitro.

Authors:  Essak S Khan; Shrikrishnan Sankaran; Lorena Llontop; Aránzazu Del Campo
Journal:  BMC Mol Cell Biol       Date:  2020-03-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.